Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/22
End: 04/15/24
Due: 04/15/25
Phase: N/A
Priority: Normal
Start: 07/31/25
End: 08/31/29
Due: 08/31/30
Phase: N/A
Priority: Normal
Start: 04/30/22
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 01/15/25
End: 01/31/26
Due: 01/31/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| AURA-2: Augmenting Urinary Reflex Activity | NCT05241379 | Amber Therapeutics Ltd | user2@example.com | None | 2022-11-30 | 2024-04-15 | 2025-04-15 | - | - | 2025-07-14 |
| Augmenting Urinary Reflex Activity Study 4 (including EXtended Indications) | NCT06885931 | Amber Therapeutics Ltd | user2@example.com | None | 2025-07-31 | 2029-08-31 | 2030-08-31 | - | - | 2025-07-14 |
| AURA 1: Augmenting Urinary Reflex Activity: Study 1 | NCT05256498 | Amber Therapeutics Ltd | user2@example.com | None | 2022-04-30 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Augmenting Urinary Reflex Activity: Study 3 | NCT06597994 | Amber Therapeutics Ltd | user2@example.com | None | 2025-01-15 | 2026-01-31 | 2027-01-31 | - | - | 2025-07-14 |